Use of Dapagliflozin in Primary Prevention of Cardiotoxicity of Anthracycline Chemotherapy in Breast Cancer Patients

Abroad (travel likely)RecruitingPHASE2

Conditions

Heart Failure · Anthracycline-induced Cardiac Toxicity · Endothelial Function (FMD) · Arterial Stiffness · Breast Cancer

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

University Medical Centre Ljubljana, Ljubljana, Slovenia
Contact: Study coordinator (Jure Tršan) · jure.trsan@kclj.si · +3861 5228011

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Expanded Studies on the SCAPIS Stockholm Reexamination Cohort

Coronary Artery Disease · Arterial Stiffness, Blood Pressure · AORTIC VALVE DISEASES

Abroad (travel likely)Recruiting

Stockholm, Sweden

EMPAgliflozin in Heart Failure With PReserved Ejection Fraction and End Stage Renal Disease

Heart Failure With Preserved Ejection Fraction · End Stage Renal Disease on Dialysis

Abroad (travel likely)RecruitingPHASE4

Hsinchu, Taiwan · Taipei, Taiwan

NORM-HF Pivotal Study

Heart Failure · NYHA Class III Heart Failure · NYHA Class II Heart Failure

Abroad (travel likely)Recruiting

Chula Vista, United States · Tulsa, United States

Strategy for EArly Recognition of Cancer, COPD & Heart Failure in the Emergency Department

Cancer · Cardiovascular · Respiratory

Abroad (travel likely)Recruiting

Glasgow, United Kingdom